Immediate Impact

1 by Nobel laureates 2 from Science/Nature 60 standout
Sub-graph 1 of 23

Citing Papers

Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
5 intermediate papers

Works of John M. Floberg being referenced

Alkylphosphocholine Analogs for Broad-Spectrum Cancer Imaging and Therapy
2014
Application of a whole-body pharmacokinetic model for targeted radionuclide therapy to NM404 and FLT
2012

Author Peers

Author Last Decade Papers Cites
John M. Floberg 226 105 151 113 27 633
Axel Van Der Gucht 187 179 181 78 33 671
Y. Watson 304 72 151 52 23 671
N. Roosen 231 98 80 198 32 664
P. Reuland 160 83 182 262 34 645
Ernest S. Owens 158 67 133 63 20 534
Takehito Sasaki 134 81 223 121 44 720
Zhenyin Liu 163 146 86 32 33 597
S. Pezzotta 119 88 142 107 43 695
So Won Oh 322 300 113 47 42 682
Gerhard Bachmaier 110 212 129 117 30 730

All Works

Loading papers...

Rankless by CCL
2026